Neuroimaging at 7 Tesla: a pictorial narrative review

Abstract

Neuroimaging using the 7-Tesla (7T) human magnetic resonance (MR) system is rapidly gaining popularity after being approved for clinical use in the European Union and the USA. This trend is the same for functional MR imaging (MRI). The primary advantages of 7T over lower magnetic fields are its higher signal-to-noise and contrast-to-noise ratios, which provide high-resolution acquisitions and better contrast, making it easier to detect lesions and structural changes in brain disorders. Another advantage is the capability to measure a greater number of neurochemicals by virtue of the increased spectral resolution.Many structural and functional studies using 7T have been conducted to visualize details in the white matter and layers of the cortex and hippocampus, the subnucleus or regions of the putamen, the globus pallidus, thalamus and substantia nigra, and in small structures, such as the subthalamic nucleus, habenula, perforating arteries, and the perivascular space, that are difficult to observe at lower magnetic field strengths. The target disorders for 7T neuroimaging range from tumoral diseases to vascular, neurodegenerative, and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, major depressive disorder, and schizophrenia. MR spectroscopy has also been used for research because of its increased chemical shift that separates overlapping peaks and resolves neurochemicals more effectively at 7T than a lower magnetic field. This paper presents a narrative review of these topics and an illustrative presentation of images obtained at 7T. We expect 7T neuroimaging to provide a new imaging biomarker of various brain disorders.

Structural MRI in Migraine: A Review of Migraine Vascular and Structural Changes in Brain Parenchyma

“…Utilizing 7 T MRI provides several advantages over clinically available 1.5 T and 3T MRI, including higher contrast-to-noise and signal-to-noise ratios; this helps generate higher-resolution images and allows for better visualization of fine structural changes in the brain. 52 As of now, it is still unclear whether certain structural changes in the brain are precursors to migraine or consequences of migraine; for that reason, more longitudinal studies would be helpful to clarify when exactly these changes occur in the timeline of migraine development, information that could help improve diagnostic and treatment decisions in the future.…”

Review of imaging test phantoms

“…An illustrative example of the impact of test phantoms on technology development is seen in the field of MRI, which has evolved from sub-1 Tesla capabilities to greater than 7 Tesla. 120 The development of advanced test phantoms in various subcategories (tube/channel, layered, and test target) for PA imaging holds great potential for accelerating the progress of this imaging technology across multiple applications. By incorporating advancements and complexities observed in phantoms used in other commercial imaging modalities, PA can benefit from existing knowledge and methodologies, thereby expediting its development process.…”

“…By studying test phantoms used in other modalities, valuable insights regarding materials, methods, and structures can be gained, accelerating the development of test phantoms for new modalities such as PA imaging. An illustrative example of the impact of test phantoms on technology development is seen in the field of MRI, which has evolved from sub-1 Tesla capabilities to greater than 7 Tesla 120 …”

5T magnetic resonance imaging: radio frequency hardware and initial brain imaging

“…Increasing the magnetic field strength of MRI systems not only improves signal-to-noise ratio (SNR) to obtain high resolution images (5)(6)(7)(8)(9), but also increases susceptibility-based contrasts in anatomical and functional imaging (10,11). Because of its high sensitivity to tissue susceptibility, ultrahigh field MRI also demonstrates potential for high resolution susceptibility weighted images (SWI) (11), which is applied for assessments of cerebral veins, stroke, multiple sclerosis, tumors or hemorrhagic lesions.…”